Thursday, 22 October 2026NewsWorldBusinessTech
Latest

Jalen Hurts Out for Season Following Pulmonary Embolism Diagnosis

Philadelphia Eagles quarterback Jalen Hurts will miss the remainder of the 2026 season following a diagnosis of deep vein thrombosis and pulmonary embolism. While the NFL has declined to investigate the team’s medical handling of the injury, the decision to allow Hurts to play in London has sparked widespread scrutiny.

Blood Clots Sideline Jalen Hurts for the Season

The Philadelphia Eagles announced that Jalen Hurts has been sidelined for the remainder of the season due to blood clots in his lungs. The diagnosis followed a series of health complications that began after Hurts sustained a calf injury during a Week 4 matchup against the Rams. According to a joint statement from the team and his agent, Nicole Lynn, the quarterback is currently undergoing treatment with blood thinners and will not be cleared for any football activities until he is off the medication.

The situation escalated significantly when it was revealed that Hurts had played in the team’s Oct. 11 game against the Jacksonville Jaguars in London after being diagnosed with a superficial blood clot in his left calf just days prior. Medical experts note that while athletes are not necessarily more predisposed to clotting than the general population, factors such as long-haul air travel can increase risks. Dr. Elizabeth Barchi, a sports medicine specialist at ChristianaCare, explained that cutting off or slowing down blood flow has serious consequences because tissues require oxygen to survive, and a pulmonary embolism—where a clot travels to the lungs—represents a life-threatening event.

NFLPA Challenges League Decision Not to Investigate Eagles

The NFL has formally stated it will not investigate the Philadelphia Eagles regarding the medical care provided to Hurts. During the league’s fall meeting, Allen Sills defended the team’s staff, describing their approach as very conservative, very patient-focused and appropriately guarded in every step.

However, the NFL Players Association (NFLPA) has publicly challenged the league’s posture. In a statement provided to media outlets, the union asserted, The NFLPA is not aware of any NFL investigation into the medical care provided to Jalen Hurts. The union further argued that a formal review is necessary to ensure players receive the highest standard of care.

Nick Sirianni Faces Questions as Hurts Contract Guarantees Decline

With Hurts sidelined, the Eagles must play the remainder of the 2026 season. Head coach Nick Sirianni has faced intense questioning regarding the team’s transparency, but he maintained that he relies entirely on his medical experts for player clearance.

Hurts is currently playing in the third season of a five-year, $255 million contract extension. Financial data from Over the Cap indicates that the deal’s guarantees decline to $22 million after this season, leaving the organization with potential flexibility to pivot at the quarterback position. As the team prepares for a season finish without their franchise leader, speculation has intensified regarding whether the Eagles will look to rebuild their coaching staff and roster starting in 2027.

NFL's top doctor defends Philadelphia Eagles handling of Jalen Hurts blood clots but NFLPA has different story
Photo: Fox News

Comparison of Athlete Health Protocols

Athlete Condition Outcome/Timeline
Jalen Hurts Deep vein thrombosis / Pulmonary embolism Out for 2026 season

While the Eagles continue to face questions about their internal decision-making, the broader sports world has seen other high-profile athletes manage similar diagnoses. NBA players Victor Wembanyama, Chris Bosh, and Damian Lillard, along with NFL player Christian Barmore, have previously dealt with blood clot conditions. Despite these precedents, the specific circumstances surrounding Hurts’ travel to London and subsequent participation in a game remain a point of contention for analysts and the NFLPA alike.